XORTX THERAPEUTICS INC (XRTX.CA) Stock Balance Sheet
TSX-V:XRTX • CA98420Q3061
0.57 CAD
+0.02 (+3.64%)
Last: Feb 12, 2026, 07:00 PM
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 35.40K | 53.70K | 95.00K | 3.82M | 13.92M | |||
| Cash Equivalents | 1.16M | 2.42M | 3.35M | 6.61M | N/A | |||
| Marketable Securities | N/A | N/A | N/A | N/A | 0.00 | |||
| Receivables | 22.10K | 17.60K | 60.70K | 81.80K | 36.10K | |||
| Other Current Assets | 141.50K | 185.40K | 560.40K | 379.60K | 889.90K | |||
| Total Current Assets | 1.36M | 2.68M | 4.07M | 10.90M | 14.13M | |||
| Non-Current Assets | ||||||||
| PPE Net | 59.60K | 34.70K | 23.90K | 92.70K | N/A | |||
| Investments And Advances | 1.20M | 1.20M | 1.20M | 1.19M | 1.13M | |||
| Intangibles | 194.00K | 183.10K | 175.30K | 199.80K | 179.50K | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 1.45M | 1.42M | 1.40M | 1.48M | 1.30M | |||
| TOTAL ASSETS | 2.81M | 4.09M | 5.47M | 12.37M | 15.43M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 59.10K | 38.80K | 11.50K | 77.60K | N/A | |||
| Accrued Expenses | 197.30K | 63.20K | 87.60K | 151.40K | 203.30K | |||
| Accounts Payable | 480.10K | 84.00K | 195.80K | 1.29M | 287.70K | |||
| Other Current Liabilities | 101.00K | 572.00K | N/A | N/A | N/A | |||
| Total Current Liabilities | 837.40K | 758.00K | 294.90K | 1.52M | 491.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | N/A | 531.00K | 3.85M | 3.22M | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 531.00K | 3.85M | 3.22M | |||
| TOTAL LIABILITIES | 837.40K | 758.00K | 825.90K | 5.38M | 3.71M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -17.49M | -15.13M | -12.39M | -9.50M | -2.31M | |||
| Additional Paid In Capital | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 19.51M | 18.52M | 17.08M | 16.55M | 14.04M | |||
| Other Shareholders' Equity | -52.60K | -52.60K | -52.60K | 6.14M | 4.77M | |||
| Shares Outstanding | 5.21M | 3.48M | 2.00M | 1.67M | 1.44M | |||
| Tangible Book Value per Share | 0.34 | 0.91 | 2.23 | 4.07 | 8.00 | |||
| Total Shareholders' Equity | 1.97M | 3.34M | 4.64M | 7.00M | 11.72M | |||
| TOTAL LIABILITIES AND EQUITY | 2.81M | 4.09M | 5.47M | 12.37M | 15.43M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 1.62 | 3.53 | 13.80 | 7.15 | 28.78 | |||
| Return On Assets (ROA) | -69.13% | -80.92% | -39.47% | -62.38% | -7.50% | |||
| Return On Equity (ROE) | -98.46% | -99.31% | -46.49% | -110.32% | -9.87% | |||
All data in USD , ROIC based on taxRate of 0.28